Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials.
Thomas G NührenbergWillibald HochholzerKambis MashayekhiMiroslaw FerencFranz-Josef NeumannPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2018)
Compared with heparin, bivalirudin was associated with a similar incidence of ischemic events following PCI for ACS. An association of bivalirudin with decreased bleeding was not seen with balanced use of GPI.
Keyphrases
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery bypass grafting
- atrial fibrillation
- coronary artery disease
- coronary artery bypass
- systematic review
- risk factors
- venous thromboembolism
- growth factor
- oxidative stress
- heart failure
- cerebral ischemia
- blood brain barrier
- left ventricular